Asthma and invasive pneumococccal diseases: the implications for clinical practice, public health and research

Research output: Contribution to journalArticle

Abstract

In the United States, the Advisory Committee on Immunization Practices now recommends a single dose of 23-valent pneumococcal polysaccharde vaccine to adults with asthma ages 19-64 years. In support of this recommendation, two independent population-based case-control studies showed that individuals with asthma have an increased risk of invasive pneumococcal diseases. In this paper, the author discusses the epidemiological relationship between asthma and invasive pneumococcal disease, and explores the potential mechanisms and the implications of these findings on clinical practice, public health and research.

Original languageEnglish (US)
Pages (from-to)S127-S131
JournalPaediatrics and Child Health
Volume19
Issue numberSUPPL. 2
DOIs
StatePublished - Dec 1 2009

Keywords

  • asthma
  • epidemiology
  • infection
  • invasive pneumococcal disease
  • risk
  • susceptibility

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Asthma and invasive pneumococccal diseases: the implications for clinical practice, public health and research'. Together they form a unique fingerprint.

  • Cite this